Abstract
The fundamental role of programmed cell death in host defense is highlighted by the multitude of anti-apoptotic strategies evolved by various microbes, including the well-known obligate intracellular bacterial pathogens Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. As inhibition of apoptosis is assumed to be essential for a successful infection of humans by these chlamydiae, we analyzed the anti-apoptotic capacity of close relatives that occur as symbionts of amoebae and might represent emerging pathogens. While Simkania negevensis was able to efficiently replicate within insect cells, which served as model for metazoan-derived host cells, the Parachlamydiaceae (Parachlamydia acanthamoebae and Protochlamydia amoebophila) displayed limited intracellular growth, yet these bacteria induced typical features of apoptotic cell death, including formation of apoptotic bodies, nuclear condensation, internucleosomal DNA fragmentation, and effector caspase activity. Induction of apoptosis was dependent on bacterial activity, but not bacterial de novo protein synthesis, and was detectable already at very early stages of infection. Experimental inhibition of host cell death greatly enhanced parachlamydial replication, suggesting that lack of potent anti-apoptotic activities in Parachlamydiaceae may represent an important factor compromising their ability to successfully infect non-protozoan hosts. These findings highlight the importance of the evolution of anti-apoptotic traits for the success of chlamydiae as pathogens of humans and animals.
Introduction
In multicellular organisms, not only cell proliferation and differentiation, but also cell death is tightly regulated to maintain tissue homeostasis and to permit proper execution of developmental processes. Apoptosis is a major physiologic process of cell elimination [1], [2], which is mediated by an internal genetic program that can be triggered by various intrinsic or extrinsic signals. It is therefore considered as a form of “programmed cell death” (PCD) [2]. Cells dying by apoptosis undergo typical morphological and biochemical changes, including cell shrinkage, plasma membrane blebbing, nuclear chromatin condensation and fragmentation, internucleosomal DNA fragmentation, and optionally break-down of the cell into apoptotic bodies [1], [3]. Under physiological conditions, dying cells and apoptotic bodies are rapidly phagocytosed by neighboring cells or professional phagocytes [1], [4]. In contrast to accidental necrosis, which is a consequence of extreme physicochemical stress resulting in cell lysis, release of cellular contents, and inflammation [5], apoptosis is thus considered as an immunological silent form of cell death that allows an economical and safe removal of superfluous cells, avoiding detrimental effects on the whole organism [1], [6].
In accordance with the concept that the capability to undergo PCD has been a prerequisite for the evolution of multicellular life, fundamental principles of the apoptotic program are highly conserved among diverse groups of multicellular animals, including mammals and other vertebrates, but also invertebrates, such as the fruit fly Drosophila melanogaster and the nematode Caenorhabditis elegans [7], [8]. Thus, despite differences in cell death regulation [9], apoptotic signaling ultimately leads to the activation of a conserved class of proteases, the caspases, which are the main executors of the death program and whose activity results in the characteristic morphological and biochemical changes that accompany apoptotic cell death [10], [11].
In addition to its role in development and tissue homeostasis, PCD is also considered as part of the immune system of animals as it enables removal of damaged and infected cells [12]. Its protective role is underscored by the multitude of anti-apoptotic strategies used by various obligate intracellular bacteria (e.g. Rickettsia rickettsii, Ehrlichia chaffeensis) and viruses (e.g. cowpox virus, baculovirus) to overcome premature death of their replicative niche [13]–[16]. Mechanisms exploited for the manipulation of the apoptotic machinery have been exceptionally well studied for bacterial pathogens within the family Chlamydiaceae [17], [18], such as Chlamydia trachomatis, which causes trachoma and sexually transmitted disease [19], [20], and Chlamydia (a.k.a. Chlamydophila) pneumoniae, which is a causative agent of pneumonia but is also associated with numerous chronic diseases [21]. The more recently discovered Parachlamydiaceae, including Parachlamydia acanthamoebae and Protochlamydia amoebophila, as well as Simkania negevensis (family Simkaniaceae), are closely related to the Chlamydiaceae, with which they also share an obligate intracellular life-style that is characterized by replication within an intracellular vacuole termed inclusion, and a biphasic developmental cycle [22]. The latter consists of an alternation between two physiologically and morphologically distinct stages, the infectious elementary bodies (EBs) and the dividing reticulate bodies (RBs) [23]. Yet, the host range of these chlamydiae differs extensively. Whereas Chlamydiaceae are pathogens of humans and animals, the Parachlamydiaceae represent natural symbionts of free-living amoebae, such as Acanthamoeba spp. [22], [24]. S. negevensis displays an exceptionally broad host range, as successful infection can be observed not only in amoebae, which have been proposed to serve as natural hosts for these bacteria in the environment [25], [26], but also in epithelial and endothelial cells, as well as macrophages of human origin [27]–[29]. These versatile infection capabilities are in good agreement with the proposed role of S. negevensis as emerging human pathogen [27]. Although the Parachlamydiaceae have also been suggested to have potential impact on human health, in particular due to evidence for a possible association with lower respiratory tract infections [30]–[33], their ability to thrive within cells derived from multicellular hosts is not very well understood. However, growth of Parachlamydiaceae within mammalian cell culture appears to be rather limited, especially if compared to infections within their natural amoebal hosts [34]–[39]. Moreover, in some studies cytotoxic effects [36] or even features of apoptotic death [35] have been reported in mammalian cells challenged with strains of Pa. acanthamoebae.
Although forms of PCD have been reported to exist in some groups of protozoa, these do not operate through the canonical apoptotic machinery of metazoans [7], [40], suggesting that microbes infecting unicellular eukaryotes do not have to struggle with this sophisticated defence mechanism. Inspired by the observations reported for the mammalian host cell system we thus hypothesized that the Parachlamydiaceae may lack the ability to actively block apoptosis, which for the pathogenic Chlamydiaceae has been shown to be an essential trait for successful completion of their developmental cycle [41]. Lack of anti-apoptotic activities may therefore represent an important factor that could universally affect the ability of Parachlamydiaceae to establish infections in cells derived from multicellular hosts thereby restricting their host range. In this study, we applied an invertebrate host cell system to test the validity of this hypothesis and to further explore the potential host spectrum of amoeba-associated chlamydiae. We show that while S. negevensis efficiently replicates in insect cells, the Parachlamydiaceae are only able to establish a successful infection in these cells if apoptosis is blocked experimentally. This finding indicates that the ability to interfere with the host's apoptosis pathway is a key mechanism determining host specificity of chlamydiae.
Results
Chlamydial symbionts of amoebae enter and replicate within insect cells
In order to further explore the infection capabilities of the Parachlamydiaceae and S. negevensis we analyzed their ability to replicate within cell lines originating from insects. Cells lines tested in this study include the phagocytic S2 cell line derived from the fruit fly Drosophila melanogaster [42], the Sf9 cell line, which is a clonal isolate of the IPLB-SF-21 cell line originating from the moth Spodoptera frugiperda [43], and the Aa23T cell line derived from the mosquito Aedes albopictus [44]. Bacteria, which were routinely cultivated within Acanthamoeba sp. UWC1, were purified from their amoebal host cells and transferred to insect cells at a defined multiplicity of infection (MOI). Addition of bacteria was followed by low speed centrifugation, which facilitates infection with chlamydiae (Fig. S1) [45]–[47], and the medium was then immediately exchanged to synchronize the infection.
Immunostaining of bacteria revealed that S. negevensis was able to efficiently enter and replicate within all three tested insect cell lines (Fig. 1). Although the proportion of infected cells was variable among cell lines, in general a MOI of 40 was sufficient to cause infections in more than 50% of all cells in infected cultures. Bacterial replication was first apparent between 24 h and 48 h post infection (p.i.) (Fig. 2A and S2). At 72 h p.i. most infected cells contained already high numbers of intracellular bacteria that appeared to be localized either within a single large inclusion or numerous smaller vacuoles. Cells that harbored only small inclusions or few single bacteria were, however, also visible at late stages, suggesting that bacterial growth did not proceed equally fast in all infected cells. Cultures infected with an MOI of 20 could be maintained by regular passage for about two to three weeks, after which cell numbers stopped to increase and finally rapidly decreased due to cell lysis. At this time point, culture supernatants contained infectious particles that could establish a second round of infection after transfer to uninfected cultures (data not shown), suggesting that S. negevensis is able to successfully complete its infection cycle within these host cells.
Pa. acanthamoebae was also able to replicate within all three insect cell lines (Fig. 1), but induced severe cytotoxic effects. Bacterial growth was first evident between 24 h and 48 h p.i., when tiny inclusions appeared in a small proportion of infected cells (Fig. 2B and S2). Intracellular vacuoles then grew in size as bacterial numbers progressively increased resulting in heavily infected cells that were first detectable at 72 h p.i. Parachlamydial inclusions seemed to be more densely packed with bacteria than those formed by S. negevensis, and as the infection proceeded, host cell nuclei appeared to be displaced by the growing vacuoles, which could not be observed during infections with S. negevensis. Immunostaining of bacteria did not allow an accurate determination of the percentage of cells containing intracellular Pa. acanthamoebae, because microscopic inspection suggested that a significant proportion of added bacteria remained firmly attached to the extracellular surface of the cells and could not be removed by additional washing steps. Efficient bacterial growth resulting in visible inclusions occurred, however, only in very few cells within infected cultures. Although higher bacterial doses might increase the infection efficiency, relatively low numbers of bacteria (MOI 0.5 to 5) were preferentially used for Parachlamydiaceae due to the strong cytotoxicity observed in cultures infected with these bacteria.
Intracellular bacteria, as well as cytotoxic effects, were also observed in insect cell cultures treated with P. amoebophila (Fig. 1), yet formation of large inclusions could not be observed even at later stages of infection. This finding is consistent with the reported growth behavior of this strain that also in amoebae appears to form rather small inclusions, containing only single or very few bacterial cells, which can be found scattered throughout the host cell [48]. In addition, as in the case of Pa. acanthamoebae, complete removal of extracellular P. amoebophila turned out to be impossible, which further complicated monitoring of the infection progress over time.
Altogether these findings indicate that the amoeba-associated chlamydiae P. amoebophila, Pa. acanthamoebae, and S. negevensis have the capacity to infect cells derived from insects and that at least the latter two are also able to replicate within these invertebrate host cells.
Parachlamydiaceae, but not Simkania, induce extensive cell death in insect cells
Infection of insect cells with Parachlamydiaceae, Pa. acanthamoebae or P. amoebophila, was accompanied by morphological changes indicative for apoptotic cell death, including cell shrinkage, cell detachment, and formation of apoptotic bodies (Fig. 3A and S3). This resulted eventually in cell lysis, which can be explained by secondary necrosis, which usually occurs in vitro subsequent to apoptotic cell death [49]. Moreover, these phenotypic changes were highly similar to those observed in response to actinomycin D (ActD), a known inducer of apoptotic death in insect cells [50] (Fig. 3A and S3). The extent of cell death induction in cultures infected with Parachlamydiaceae was dependent on the bacterial dose, yet formation of apoptotic bodies was even visible at very low MOIs, such as MOI 0.01. The time course of cellular disintegration, however, appeared to be independent of the amount of bacteria added, and morphological changes were detectable as early as 6 to 8 h p.i. Cell death did not proceed synchronously in all cells of infected cultures; its onset seemed to be delayed in some cells and few individual cells even resisted disintegration over several days. In contrast to Parachlamydiaceae, S. negevensis did not induce appreciable extents of early host cell death at comparable low MOIs (≤5) (Fig. 3A and S3), though very high bacterial doses also resulted in morphological alterations indicative for apoptotic cell death.
Parachlamydiaceae-induced cell death represents caspase-dependent apoptosis and occurs early during infection
The pathogenic Chlamydiaceae are able to efficiently block the apoptotic machinery in infected mammalian cells [17], [18]. Although host cell death that resembles apoptosis has occasionally been reported to occur at the end of their infection cycle, this appears to be a clearly distinct mode of cellular demise, as it proceeds in the absence of caspase activation [17], [18]. We were therefore interested in a more detailed characterization of the nature of Parachlamydiaceae-induced cell death. In particular, we aimed to clarify whether it was accompanied by typical biochemical hallmarks of apoptotic cell death, such as changes in nuclear morphology and internucleosomal DNA fragmentation, and whether it involved activation of apoptotic effector caspases.
Nuclear morphology was analyzed microscopically after staining with the DNA dye 4′,6-diamidino-2-phenylindole (DAPI). Whereas most nuclei in untreated control cultures and cultures infected with Simkania displayed a normal morphology, a marked increase in condensed and fragmented nuclei, indicative for apoptotic cell death [51], was visible not only in cells treated with ActD, but also in cultures infected with Parachlamydiaceae (Fig. 3A and S3). Condensed nuclear fragments were detected in both dying cells and apoptotic bodies.
We next investigated whether Parachlamydiaceae-induced cell death was also characterized by DNA fragmentation. Electrophoretic separation of DNA isolated from Sf9 cultures that were infected with Pa. acanthamoebae or P. amoebophila revealed a DNA ladder consisting of bands that were multiplies of about 180–200 bp in size (Fig. S4). This band pattern, which is typical for apoptotic internucleosomal DNA fragmentation [52], [53], could also be observed after experimental apoptosis induction by ActD. In contrast, only high molecular weight DNA was detectable in untreated control cells. For unknown reasons, apoptotic DNA ladders could neither be detected in infected S2 cells nor in S2 cultures treated with ActD, despite detectable cell death induction. We therefore additionally applied the TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labelling) assay [54], which allows in situ detection of DNA strand breaks in host nuclei, as alternative technique. This method not only confirmed occurrence of DNA fragmentation in infected Sf9 cultures (Fig. S5), but an increase in TUNEL-positive cells, compared to untreated cultures, was also detectable for infected S2 cells (Fig. 3B). TUNEL-staining was also observed after ActD treatment and moreover typically coincided with other features of apoptotic cell death, such as nuclear condensation and formation of apoptotic bodies that frequently also contained TUNEL-positive, condensed nuclear fragments.
Finally, we investigated whether Parachlamydiaceae-induced cell death also involved activation of apoptotic effector caspases. We used an in vitro enzyme assay based on a fluorimetric substrate containing the peptide DEVD, which is specifically cleaved by mammalian effector caspases and homologous enzymes in insects [10], [11]. As initial experiments indicated DEVD cleavage activity in response to infection with Parachlamydiaceae (data not shown), we applied this assay to monitor effector caspase activity in both cell lysates and supernatants of S2 and Sf9 cultures over three consecutive days of infection with Pa. acanthamoebae, P. amoebophila, or S. negevensis in order to obtain a more comprehensive picture of the extent and time course of cell death induction. Compared to untreated control cells, significantly elevated cleavage activity could be observed in S2 and Sf9 cells that were either incubated with ActD or infected with Parachlamydiaceae (Fig. 4 and S6) (ANOVA & Scheffé, p≤0.001). Moreover, the pan caspase inhibitor Z-VAD-FMK [55] was not only able to completely inhibit DEVD cleavage, but also all other signs of cell death usually observed at early stages of infections with Parachlamydiaceae. Consistent with the observation that S. negevensis does not induce appreciable host cell death at an equivalent bacterial dose, only a slight, though statistically significant (p≤0.001), increase in DEVD cleavage activity could be observed after infection with these bacteria (Fig. 4 and S6).
An increase of DEVD cleavage activity in S2 and Sf9 cells infected with Parachlamydiaceae was first visible as early as 6 h or 8 h p.i., respectively. A statistically highly significant difference (p≤0.001) compared to 0 h p.i. was first detected after 8 h in S2 cells and after 24 h in Sf9 cells. DEVD cleavage activity in cell lysates initially increased over time, but was then followed by a marked decline, which most likely reflects a transition from early apoptotic to late apoptotic/secondary necrotic cells. Consistently, decreasing cleavage activity in lysates was also accompanied by an increasing activity detectable in culture supernatants, which indicates release of active caspases from secondary necrotic cells.
In conclusion, these data demonstrate that Parachlamydiaceae-induced cell death in insect cells is indeed of apoptotic nature and depends on effector caspase activity. The combination of DAPI and TUNEL staining with immunodetection of bacteria moreover revealed that dying cells were frequently associated with bacteria, yet cell death induction was not restricted to infected cells, but also occurred in uninfected cells within infected cultures. Consistent with our morphological observations of cell death, Parachlamydiaceae-induced apoptosis in insect cells starts at a very early stage of infection and in vitro rapidly proceeds to secondary necrosis.
Apoptosis induction by Parachlamydiaceae depends on bacterial activity
As a first step to decipher how Parachlamydiaceae may induce apoptosis, we aimed to analyze the specific requirements for cell death induction. In particular, we were interested in the question whether only infectious bacteria had this capacity or whether cell death might in fact be caused by cytotoxic factors or bacterial cell constituents present in chlamydial preparations. In addition, we wanted to exclude that apoptosis was triggered by cell debris originating from the amoebae from which the bacteria were purified. For this purpose S2 and Sf9 cells were subjected to diverse treatments followed by monitoring of morphological changes using phase contrast microscopy and quantitative evaluation of nuclear morphology 48 h after treatment.
Based on morphological observations, cell death induction could only be detected after addition of infectious Parachlamydiaceae (MOI 5) and to a much lower extent also after infection with ten times higher doses of S. negevensis (MOI 50) (data not shown). A statistical significant increase in altered nuclei compared to untreated control cells was, however, only induced by infectious Parachlamydiaceae (ANOVA & Scheffé, p≤0.001), but not by S. negevensis (MOI 5 or 50) (Fig. 5 and S7). Significant changes in nuclear morphology could also not be observed in response to heat- or UV- inactivated Parachlamydiaceae, sterile filtrates of suspensions of purified infectious bacteria or lysates of Acanthamoeba sp. UWC1 (p>0.05), indicating that apoptosis induction depends on viable, infectious Parachlamydiaceae. However, de novo bacterial protein synthesis was dispensable, as induction of cell death was unaffected by doxycycline, an inhibitor of bacterial translation. Doxycycline was applied at a concentration above the minimal inhibitory concentration (MIC) reported for Pa. acanthamoebae strains Bn9 and Hall's coccus [34], which in our study additionally appeared to be nontoxic for insect cells, but sufficient to effectively block growth, but not entry, of Pa. acanthamoebae in S2 cells (data not shown). Moreover, supernatants collected 48 h after infection with Parachlamydiaceae from clearly apoptotic cultures did not induce significant nuclear alterations after transfer to uninfected cultures (p>0.05), suggesting the absence of cell death stimulating factors in culture supernatants at this time (Fig. 5 and S7).
Consistent with these findings, heat- and UV-inactivated Parachlamydiaceae did not trigger internucleosomal DNA fragmentation as indicated by absence of apoptotic DNA ladders in treated Sf9 cells (Fig. S4). Moreover, in response to heat-inactivated bacteria no increase in effector caspase activity was detected in S2 and Sf9 cells (Fig. 4 and S6). Together these results strongly suggest that apoptosis induction by Parachlamydiaceae requires the activity of infectious bacteria, but is independent of de novo synthesis of bacterial proteins.
Experimental inhibition of apoptosis enhances infection with Parachlamydiaceae
The time course of apoptosis induction by Parachlamydiaceae suggested that the infection progress might be severely compromised due to an early disruption of chlamydial development. In order to test this hypothesis, we undertook a quantitative comparison of infections of S2 and Sf9 cells with Pa. acanthamoebae or S. negevensis in the absence or presence of the pan caspase inhibitor Z-VAD-FMK. At ten time points during a total period of 14 days the percentage of infected cells and the number of intracellular bacteria per cell were determined. To achieve an accurate quantification, which should be less affected by extracellularly attached bacteria compared to immunostaining, fluorescence in situ hybridization (FISH) targeting ribosomal rRNAs [56], [57] was used for the detection of bacteria. Although FISH may lead to an underestimation of the infection at early stages, its ability to predominately detect metabolically highly active bacteria, compared to inactive or dead bacteria [57], was considered as major advantage of this technique.
Consistent with our earlier results (Fig. 2A and S2) intracellular replication of S. negevensis in absence of Z-VAD-FMK was not detectable in S2 and Sf9 cells within the first 24 h, after which bacterial numbers in infected cells, however, increased (Fig. 6 and S8). Starting from 72 h p.i., when cells that were densely filled with bacteria first appeared, cells reflecting variable stages of infections were visible throughout the two weeks of analysis. In the presence of Z-VAD-FMK, infections with S. negevensis proceeded similarly, although the growth in S2 cells appeared to be slightly slowed down. At the end of the analysis period a significant increase in the proportion of infected S2 cells compared to 0 h p.i. (ANOVA & Scheffé, p≤0.001), probably indicating release of infectious progeny and onset of the second round of infection, was visible in the absence of Z-VAD-FMK. Interestingly, although the same trend was also detectable when the caspase inhibitor was present, the increase in the percentage of infected cells was much smaller and in fact turned out to be not statistically significant (p>0.05). In case of the Sf9 cells, we did not observe a marked increase in the proportion of infected cells during the analysis period, which may indicate inefficient bacterial spread or may be explained by the fact that bacterial growth appeared to be in general delayed in this cell line.
In the absence of Z-VAD-FMK, infections with Pa. acanthamoebae were inefficient in both cell lines, as most infected cells contained only few intracellular bacteria throughout the two weeks of analysis (Fig. 7 and S8). After 24 h increased numbers of bacteria were detectable in a small proportion of infected cells, indicating the onset of bacterial replication. Yet, heavily infected cells (containing more than 100 bacteria) were hardly observed and constituted less than 1% of the infected cells at all time points analyzed. Interestingly, a slight but continuous increase in the percentage of infected cells over time was, nevertheless, observed in both cell lines. This may, however, be explained by delayed entry of bacteria that originally remained attached after the initial inoculation or by engulfment of infected apoptotic cells by neighboring cells.
In S2 cells infections with Pa. acanthamoebae were greatly enhanced by addition of Z-VAD-FMK (Fig. 7). Even though the initial steps including attachment and entry appeared to be unaffected by the treatment, bacterial growth, which was first detectable in few infected cells at 24 h p.i., occurred very rapidly under conditions of apoptosis inhibition. After 48 h, about 45% of the infected cells contained already large inclusions, hence the infection progress was significantly improved compared to infections that occurred in the absence of the caspase inhibitor (χ2 test, p≤0.01). Moreover, a strong increase in the percentage of infected cells, which was also accompanied by the onset of detectable cell lysis, was already visible at this early time point. Although infections with Pa. acanthamoebae in Sf9 cells were also significantly improved by caspase inhibition (Fig. S8), reinfection appeared to be less efficient in this cell line, which after an initial increase even resulted in a drop in the percentage of infected cells at later time points, possibly due to dilution effects introduced by passaging.
At the ultrastructural level, infection of apparently intact S2 cells with Parachlamydiaceae – including Pa. acanthamoebae, but also P. amoebophila – could be observed in the presence of Z-VAD-FMK, whereas almost all cells appeared to be in a late stage of cellular disintegration after 2 days of infection in the absence of the caspase inhibitor (Fig. S9).
In conclusion, whereas the growth of S. negevensis in insect cells was largely unaffected by the caspase inhibitor Z-VAD-FMK, experimental apoptosis inhibition strongly enhanced infections with Pa. acanthamoebae, most likely as a result of the protection of their replicative niche.
Discussion
Chlamydiae show a broad host range and pronouncedly different life styles ranging from ubiquitous symbionts of amoebae to highly successful pathogens of humans and animals. This raises the question which underlying molecular mechanisms for host cell interaction are responsible for these differences. In this study we present evidence based on an invertebrate host cell system that the ability to block apoptosis is a key trait required for the successful infection of metazoans.
We showed that S. negevensis, which is known to infect both protozoa and mammalian cells [25], [26], [28], [29], is also able to replicate within insect cells. This was demonstrated by application of two different fluorescence-based detection techniques, immunostaining and FISH, coupled to conventional as well as confocal fluorescence microscopy (Fig. 1, 2A, 6, S2, and S8). Interestingly, although insect cells containing large amounts of intracellular bacteria could be observed as early as three days post infection, cell lysis and reinfection were not evident during the first 10 days of infection. A similarly long infection cycle consisting of a short exponential growth phase followed by a long plateau phase devoid of significant release of infectious progeny has been reported for S. negevensis in Vero cells grown at 37°C [58]–[60]. We thus exclude that our observation can be solely explained by the lower incubation temperature applied for insect cell culture (27°C). This delayed infection cycle of S. negevensis contrasts with the duration of those of members of the Chlamydiaceae and Parachlamydiaceae, which are typically completed within 2–5 days within their mammalian or amoebal host cells, respectively [61], [62]. Our observations suggest that the extended developmental cycle of S. negevensis may represent a general feature of these chlamydiae.
Drosophila S2 cells are an excellent model for the discovery of host factors involved in host-pathogen interactions through RNA interference based screens [63]–[65], and the ability of S. negevensis to thrive within insect cells may therefore be of great value for future studies. It, however, also raises the question whether an association of chlamydiae with arthropods might be in fact more widespread in the environment than known so far. Indeed several chlamydial species that are closely related to S. negevensis, such as Fritschea bemisiae and Fritschea eriococci (family Simkaniaceae) [66] as well as Rhabdochlamydia crassificans and Rhabdochlamydia porcellionis (family Rhabdochlamydiaceae) [67], [68], have been described to naturally infect insects or other arthropods. Moreover, S2 cells were shown to support growth of the well-known chlamydial pathogens C. trachomatis [69] and C. caviae [63], although formation of infectious progeny within these cells has so far only been reported for the latter of these two species and, as for S. negevensis, their capability to infect living insects remains to be elucidated.
The Parachlamydiaceae are naturally associated with amoebae but, in contrast to S. negevensis, do not efficiently thrive within mammalian cells [34]–[39]. Consistent with this notion, although Parachlamydiaceae are able to invade insect cells, they rapidly triggered cell death, whose apoptotic nature was inferred from the following observations: (i) phase contrast and fluorescence microscopy revealed that dying cells displayed morphological and nuclear changes indicative for apoptotic cell death [1], [51] (Fig. 3A, 5, S3, and S7); (ii) DNA fragmentation could be detected by two independent techniques, including visualization of nucleosomal DNA ladders on agarose gels [52] and the TUNEL method [54] (Fig. 3B, S4, and S5); (iii) an in vitro enzyme assay revealed cleavage activity towards a peptide substrate containing DEVD (Fig. 4, and S6), which is specifically cleaved by apoptotic effector caspases [10], [11]; and (iv) cell death could be completely blocked by the pan-caspase inhibitor Z-VAD-FMK (Fig. 4 and S6).
In animals, apoptotic death of infected cells is regarded as defense mechanism, which may in particular be highly effective in the battle against intracellular pathogens that rely on an intact host cell [13], [70]. This concept is well exemplified by infections with viruses such as the baculovirus Autographa californica, for which it has been demonstrated that disruption of a viral anti-apoptotic gene significantly reduces not only viral replication in insect cell culture, but also infectivity in Spodoptera frugiperda larvae [71], [72]. Likewise, Chlamydiaceae actively block apoptotic cell death in infected mammalian cells [73]–[77], and a very recent report described the inhibition of cell death by S. negevensis in human cells [78]. Experimental induction of premature host cell death has been reported to completely disrupt development of C. trachomatis, preventing formation of infectious progeny [41]. Maintenance of host cell viability for prolonged periods of time has also been suggested to be important during persistent chlamydial infections [79]. At late stages of infection, however, intracellular pathogens such as chlamydiae may also benefit from apoptotic host cell death, as engulfment of bacteria-loaded apoptotic bodies by neighboring cells may facilitate pathogen spread [17], [80]. Indeed it has been repeatedly reported that at the end of their infection cycle also Chlamydiaceae induce host cell death that shares some features with apoptosis, including externalization of phosphatidylserine that may enhance phagocytic uptake of dying cells [80], but which is clearly distinct from the apoptotic program as numerous studies failed to detect any involvement of apoptotic effector caspases [81]–[84]. However, even though the interaction of the Chlamydiaceae with the host cell's suicide machinery has been subject to detailed investigation during the last decades, the molecular mechanisms underlying chlamydial death-stimulating activities are still poorly understood. In addition, the significance of this apoptosis-like cell death in the context of infection and pathogen spread remains obscure. Host cell lysis and extrusion of bacteria-loaded vesicles have recently been suggested to represent the main mechanisms of host cell exit by Chlamydiaceae [85].
Nevertheless, the Chlamydiaceae have been convincingly shown to exploit a whole battery of strategies to prevent apoptotic death in mammalian host cells [17], [18]. The fact that C. trachomatis and C. caviae were shown to grow in Drosophila S2 cells without induction of apoptosis [63], [69] suggests that these bacteria may as well have the capacity to block cell death in these invertebrates. However, despite of the evolutionary conservation of the apoptotic core machinery, apoptosis regulation differs significantly between mammals and insects [9]. In mammals, mitochondrial outer membrane permeabilization resulting in the release of factors required for caspase activation is a central step in most apoptotic pathways and tightly regulated by the balance of anti- and pro-apoptotic proteins [86]. Chlamydiaceae interfere with this balance in infected cells by diverse mechanisms including degradation of the pro-apoptotic BH3-only proteins [87]–[89] and upregulation of anti-apoptotic proteins, such as Mcl-1 [90]–[92], which together confer a block of the apoptotic program at a pre-mitochondrial step. Yet in insects, although still controversial, it is assumed that caspase activation occurs independently from mitochondrial factors and that the IAP (inhibitor of apoptosis) proteins, which can directly inhibit caspases, instead play a central role in the regulation of apoptosis [93]. Interestingly, Chlamydiaceae – and very recently also S. negevensis – have been shown to trigger up-regulation of IAPs in infected mammalian cells [78], [94], [95], and a similar strategy if operational may be a highly effective mechanism to block cell death in insects as well.
In case of the Parachlamydiaceae, the observation that the pan caspase inhibitor Z-VAD-FMK greatly improved growth of Pa. acanthamoebae in insect cells (Fig. 7) clearly illustrates that premature host cell death is highly disadvantageous for these bacteria. This is consistent with the very early time point of apoptosis induction (Fig. 4 and S6), resulting in disruption of intracellular parachlamydial development. Although infections with P. amoebophila were not quantitatively analyzed in this study, we observed that early host cell death induced by these Parachlamydiaceae could also be completely blocked by the pan caspase inhibitor, and apparently intact infected cells were readily visible under such conditions. Beside its inhibitory action on caspases, Z-VAD-FMK has also been shown to affect the activity of certain lysosomal proteases, such as cathepsins [96], [97]. Given that, at least in human macrophages, Pa. acanthamoebae has been reported to not escape from the endocytic pathway – as observed for other chlamydial species [98], [99] – but to reside within vacuoles that acquire markers of late endosomes and even acidify [99], [100], it is conceivable that impaired lysosomal function may provide an additional benefit for the intracellular growth of Pa. acanthamoebae. Yet, we could observe that the pan caspase inhibitor Q-VD-OPH, which is considered to be less cross-reactive with lysosomal proteases than Z-VAD-FMK [101], has an equal capacity to enhance parachlamydial growth in insect cells (data not shown), which strongly indicates that the growth-promoting activity of Z-VAD-FMK was indeed due to the inhibition of the canonical apoptotic machinery. In view of this finding it may be an interesting task of future investigations to elucidate whether co-infections with other intracellular pathogens, which effectively antagonize the host's apoptotic response, may have a similar impact on the outcome of infections with Parachlamydiaceae.
How Parachlamydiaceae induce cell death in insect cells remains so far unknown. It has been reported that exposure to cell constituents of Chlamydiaceae, such as lipopolysaccharide or heat shock proteins, could trigger apoptosis in certain cell types [102]–[104]. In addition, due to the known cytotoxicity of Acanthamoeba spp. [105], we initially suspected that amoebal cell debris, and not the bacteria themselves, could be responsible for the observed effect. However, as inactivated bacteria, filtrates of bacterial suspensions, and lysates of Acanthamoeba sp. all failed to induce any signs of apoptotic cell death (Fig. 4, 5, S4, S6 and S7), we ruled out these possibilities. Infections with extremely high doses of Chlamydiaceae were shown to cause a necrotic type of death in mammalian cells, which is characterized by cellular disintegration starting immediately after challenge with the bacteria. It has been hypothesized that this so-called “immediate cytotoxicity” of chlamydiae may be due to physical damage caused by the ingestion of high amounts of bacterial particles [106]–[108]. We exclude that Parachlamydiaceae-induced cell death in insect cells can be explained by this phenomenon because of (i) the moderate to low MOIs applied in our study, (ii) the particular timing of cell death which is pronouncedly delayed compared to “immediate cytotoxicity”, and (iii) the observed apoptotic features. In the case of the pathogenic Chlamydiaceae, it has also been hypothesized that either the chlamydiae or chlamydia-infected cells may secrete death-stimulating factors, such as toxins or cytokines, into the culture supernatant, based on the observation that apoptosis was frequently observed in uninfected cells within infected cultures [81], [82], [109], [110]. Although in our study the combination of DAPI and TUNEL staining with immunodetection of bacteria also suggested that cell death induction was not exclusively restricted to infected cells, we did not observe an apoptosis-stimulating activity in supernatants of infected clearly apoptotic cultures (Fig. 5 and S7), indicating that such a factor does either not exist or must be highly unstable and only transiently detectable. Consistent with observations from infections of S2 cells with C. caviae [63] an alternative explanation for apoptosis induction in uninfected cells would be that cells that appeared to be uninfected at the time of analysis had originally been invaded by bacteria that were subsequently cleared by lysosomal degradation. It is also conceivable that apoptosis induction is independent of bacterial entry. Transient contact, including bacterial attachment and possibly even secretion of bacterial effector molecules into the host cell, might already be sufficient to trigger the apoptotic program. However, the fact that apoptosis induction was not affected by the bacterial protein synthesis inhibitor doxycycline (Fig. 5 and S7) indicates that bacterial factors involved in host cell killing already exist preformed in the bacteria present in the inoculum.
Although the Parachlamydiaceae lack genes encoding homologues of known chlamydial toxins, such as CADD (Chlamydia protein associating with death domains) [111] and proteins related to clostridial cytotoxins [112], their genomes encode numerous proteins of unknown function [113]–[115], and the presence of yet unrecognized toxin genes can therefore not be excluded. Alternative to the production of a genuine toxin, it is, however, equally well conceivable that the apoptotic program is triggered more indirectly through disturbance of host cell functions, which might be sensed by host cells through general stress sensors. Such an intrinsic pro-apoptotic action has also been attributed to the Chlamydiaceae, which, besides the need to protect mammalian host cells from effector T cell mediated killing [116], [117], has been suggested to have been a major driving force for the evolution of effective counteracting strategies [13]. In view of this perspective, it may be possible that the extant amoeba-associated Parachlamydiaceae, in addition to the lack of critical anti-apoptotic activities, may also have retained death-stimulating factors, which have been lost in other chlamydiae during the adaptation to multicellular hosts.
In summary, we present evidence that apoptosis is an effective host defense mechanism against Parachlamydiaceae in insect cells. Reports about cytotoxicity and apoptosis induction by Parachlamydiaceae in mammalian cell culture suggest that this concept is not restricted to insect hosts, but represents a more universal phenomenon across potential multicellular hosts of Parachlamydiaceae. We therefore conclude that the development of the ability to block apoptosis was a key step during the evolution of the Chlamydiae, which facilitated the transition from protozoa to metazoan hosts.
Materials and Methods
Cell culture
The insect cell lines S2 (Drosophila melanogaster) [42] and Aa23T (Aedes albopictus) [44] were maintained at 27°C in Schneider's insect medium (Sigma-Aldrich, Austria) supplemented with 10% heat-inactivated (56°C, 30 min) fetal bovine serum (PAA Laboratories, Austria). The insect cell line Sf9 (Spodoptera frugiperda) [43] was maintained at 27°C in Grace's insect medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (PAA Laboratories) and 2 mM L-glutamine (Sigma-Aldrich). Cells were regularly passaged at confluency. Insect cell cultures were shown to be free of contamination with Mycoplasma spp. by using the Venor GeM PCR kit (BioProducts, Austria). Acanthamoeba sp. UWC1 containing the chlamydial symbionts P. amoebophila UWE25 [48], Pa. acanthamoebae UV7 [36], or S. negevensis Z [60], [118] and symbiont-free isogenic amoebae were maintained at 20°C in TSY medium (30 g/l trypticase soy broth, 10 g/l yeast extract).
Purification of chlamydial symbionts
Amoebae containing chlamydial symbionts were harvested at 3200× g and washed with Page's amoebic saline (PAS; 0.12 g/l NaCl, 0.004 g/l MgSO4×7H2O, 0.004 g/l CaCl2×2H2O, 0.142 g/l Na2HPO4, 0.136 g/l KH2PO4). Cells were resuspended in a small volume PAS and disrupted by three consecutive cycles consisting of freezing (dry ice/ethanol bath) and thawing (37°C). Then 0.5 volumes sterile glass beads (0.75–1.00 mm) were added, followed by vortexing for 3 min and centrifugation (620× g, 10 min). The supernatant was filtered (1.2 µm) and bacteria were collected by centrifugation (35 700×g, 45 min) in an Optima™ L-100 XP ultracentrifuge equipped with SW41 Ti rotor (Beckman Instruments, USA). Bacteria were resuspended in a small volume of sucrose-phosphate-glutamate (SPG) buffer (75 g/l sucrose, 0.52 g/l KH2PO4, 1.53 g/l Na2HPO4×2H2O, 0.75 g/l glutamic acid) and the suspension was homogenized using needles (diameter 0.90 mm and 0.45 mm). Bacteria were collected by centrifugation (as described above), resuspended in SPG, and homogenized. Aliquots of purified bacteria were stored at −80°C. If not stated otherwise, all steps during the purification were carried out at 4°C. Number of bacterial particles were determined by counting of bacteria, which were filtered onto a 0.2 µm filter (Milipore, Austria) and stained with 4′,6-diamidino-2-phenylindole (DAPI), at an epifluorescence microscope (Axioplan 2 imaging; Zeiss, Germany). To verify the identity of the chlamydiae, DNA was extracted from purified bacteria using the DNeasy blood & tissue kit (Qiagen, Austria) and the chlamydial 16S rRNA gene was amplified using a pan-chlamydia primer set described elsewhere [119]. PCR products were sequenced on an ABI 3130 XL genetic analyzer (Applied Biosystems, Austria) and compared to sequence data available at NCBI.
Infection procedure and apoptosis induction
Insect cells seeded into 24-well plates (Nunc; 5×105 cells per well), 12-well plates (Nunc; 1×106 cells per well), 8-well Lab Tek™ chamberslides (Nunc; 1×105 cells per well), or culture flasks (Iwaki, 25 cm2; 6×106 cells) were infected using a defined MOI. For microscopic analyses, infections were performed on cells seeded either in chamberslides or on glass coverslips in 24-well plates. Addition of the bacteria was followed by centrifugation (130× g, 15 min, 23°C), exchange of growth medium, and incubation at 27°C until analysis. If indicated apoptosis was induced by addition of 2 µg/ml actinomycin D (ActD; Sigma-Aldrich) to the growth medium followed by incubation for indicated periods of time.
Immunostaining and DAPI staining
Insect cells were fixed with 100% methanol (ice-cold, 5 min), washed once with phosphate-buffered saline (PBS), and blocked for 20 min in 2% bovine serum albumin (BSA) in PBS. Cells were then incubated for 1 h with primary antibodies diluted in blocking solution. Primary antibodies used in this study include polyclonal antibodies (Eurogentec, Belgium) raised against P. amoebophila UWE25 or Pa. acanthamoebae UV7, which were purified on gastrografin gradients [120], or against purified recombinant protochlamydial heat shock protein DnaK (pc1499). Antisera were pre-adsorbed with host proteins as described recently [120]. After three washing steps in PBS, cells were incubated for 1 h with Cy2- or Cy3-labelled secondary antibodies (Dianova, Germany) diluted in blocking solution, followed by three additional washing steps. DNA was stained for 10 min with DAPI (100 ng/ml in PBS). Cells were then washed twice with PBS and embedded in Mowiol [120]. Images were taken with a CCD camera (AxioCam HRc; Zeiss) connected to an epifluorescence microscope (Axioplan 2 imaging; Zeiss).
Infection analysis by FISH
Insect cells seeded in 24-well plates were infected (as described above) and the pan-caspase inhibitor Z-VAD-FMK (10 µM; Promega, USA) was added to half of the wells, but was omitted in the others. Infections were analyzed at 0, 5, 10, 24, 48, 72, and 96 h p.i., however at 48 h p.i. the caspase inhibitor was replenished in the respective remaining wells to assure efficient caspase inhibition. In order to enable analysis of later time points (7, 10, and 14 days p.i.), cells from additional wells were passaged (1∶3) into new wells at 72 h p.i. At the time points indicated, cells were fixed by addition of one volume of a 4% formaldehyde solution to the growth medium, followed by incubation for 1 h at room temperature. Cells were then washed once with PBS and dehydrated by incubation in increasing concentrations of ethanol (50%, 80% and 96%, 3 min incubation with each). Hybridizations were performed for 3 h at 46°C at a formamide concentration of 25%, using hybridization and wash buffers described elsewhere [121]. The following fluorescently labelled (Cy3, Cy5, or Fluos) probes (Thermo Fisher Scientific, Germany) were applied in this study: EUK-516 (5′- ACCAGACTTGCCCTCC -3′) [122] for the detection of eukaryotic host cells, Chls0523 (5′-CCTCCGTATTACCGCAGC-3′) in combination with the competitor probe (5′-CCTCCGTATTACCGCGGC-3′) [56] as general probe for the detection of all chlamydiae used in this study, and UV7-763 (5′-TGCTCCCCCTTGCTTTCG-3′) [36] and Simneg183 (5′-CAGGCTACCCCAGCTC-3′) for the specific detection of Pa. acanthamoebae UV7 and S. negevensis Z, respectively. Cells were embedded in Mowiol and images were taken at the epifluorescence microscope and at a confocal laser scanning microscope (LSM 510 Meta; Zeiss). The percentage of infected cells and the number of intracellular bacteria within infected cells were determined. Both normal and dying cells were considered. For each time point and condition, data from three replicate infections were collected. In general, at least 500 cells were counted per sample. However, in case of infections of S2 cells with Pa. acanthamoebae UV7 in presence of Z-VAD-FMK, only a lower number of cells (at least 200 cells per well) could be analyzed for some replicates of later time points (7, 10, and 14 days p.i.) due to highly reduced cell numbers caused by cell lysis.
Evaluation of nuclear morphology
To test for the requirement of bacterial activity for cell death induction, insect cells seeded in 24-well plates were either treated with infectious bacteria (in the presence or absence of 10 µg/ml doxycycline) or with an equivalent amount of SPG buffer or heat-inactivated (56°C, 30 min) or UV-inactivated (Transilluminator UST-30M-8E (Biostep, Germany), 15 min) bacteria, three times the amount of a sterile-filtrate (0.2 µm) of the suspension of purified bacteria, or different amounts of an amoebal lysate (20 µl or 100 µl). Centrifugation and medium exchange were carried out as described for the standard infection procedure, yet these steps were omitted in wells where 100 µl amoebal lysate were added. In an additional experiment, the growth medium of hitherto untreated cells was replaced by sterile-filtered supernatant of an infected culture, collected 48 h p.i. For the preparation of amoebal lysates, four culture flasks (25 cm2) containing Acanthamoeba sp. UWC1 (in total approximately 2×107 cells) were harvested (3200× g, 10 min). Amoebae were resuspended in 1 ml PBS and lysed by 3× freeze-and thaw (see above). The lysate was filtered (1.2 µm) and stored at −80°C. The efficiency of heat- and UV-inactivation of bacteria was tested by infection of amoebae, which revealed strongly decreased, but not completely abolished, infectivity of inactivated bacteria (data not shown). After incubation for 48 h at 27°C, treated cells were fixed with methanol and subjected to immunostaining and DAPI staining, as described above. The percentage of condensed and/or fragmented nuclei was determined for three independent experiments (of each condition mentioned above), each consisting of two replicate wells. At least 500 nuclei per replicate were counted.
Detection of apoptotic DNA fragmentation by TUNEL staining
Infected and control cells grown in 24-well plates or chamberslides were fixed with formaldehyde as described for FISH. Cells were then permeabilized in 0.1% Triton-X 100, 0.1% sodium citrate for 10 min and blocked with 2% BSA in PBS for 20 min. Immunostaining of bacteria occurred as described above. The TUNEL reaction was carried out according to the instructions of the in situ cell death detection kit (Roche, Austria). In case of the TUNEL positive control, cells were pre-incubated with DNase I (Sigma-Aldrich; 100 U/ml in 50 mM Tris/HCl, 1 mg/ml BSA, pH 7.5) for 10 min. For the negative control, cells were incubated in labelling solution devoid of the enzyme terminal deoxynucleotidyl transferase (TdT). Cells were finally embedded in Mowiol and analyzed at the epifluorescence microscope.
Detection of caspase activity
Infected and control cells grown in 12-well plates were incubated for indicated periods of time. Culture supernatants were collected and centrifuged (3800× g, 10 min, 4°C) to remove residual cells. Cell lysates were prepared by addition of 150 µl lysis buffer (50 mM HEPES (pH 7.4), 5 mM CHAPS, 5 mM DTT) to each well followed by incubation on ice for 20 min. Lysates were centrifuged (20 800× g, 10 min, 4°C) to remove insoluble cell debris. Samples were stored at −80°C until analysis. Effector caspase activity was measured using a fluorimetric caspase 3 assay kit (Sigma-Aldrich) and a Tecan Infinite M200 plate reader (Tecan, Austria). For each measurement, 5 µl lysate or 20 µl supernatant were applied. Each sample was analyzed in duplicate (technical replicates) and data were collected for at least four replicate infections (biological replicates). Values are presented as arbitrary relative fluorescence units without normalization.
Statistical analysis
Data obtained for the analysis of nuclear morphology, for monitoring of caspase activity, and for the analysis of the proportion of infected cells during the course of infection, were analyzed using one-way analysis of variance (ANOVA) to test for statistical significant (p≤0.05) differences between groups. Scheffé's post hoc test was then applied to specify groups that significantly (***, p≤0.001; **, p≤0.01; *, p≤0.05) diverged from the untreated control (nuclear morphology) or 0 h p.i. (caspase activity, percentage of infected cells). The unpaired student's t-test was additionally applied to compare the percentage of infected cells between infections that occurred in the absence or presence of Z-VAD-FMK for each time point. All three tests were carried out using the software PASW statistics version 17. In the case of the infection analysis by FISH, infected cells were additionally classified into different groups according to their number of intracellular bacteria. A χ2 test was used to compare the distribution of cells among these groups for each time point between infections carried out in absence or presence of Z-VAD-FMK (***, p≤0.001; **, p≤0.01; *, p≤0.05).
Supporting Information
Acknowledgments
The authors would like to thank Georg Häcker from the Institute of Medical Microbiology and Hygiene (University of Freiburg, Germany) for excellent advice and valuable discussions. Federico Mauri (Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Austria), Masato Yonezawa (University of Tokyo, Japan), and Jason L. Rasgon (Johns Hopkins University, USA) are gratefully acknowledged for providing S2, Sf9, and Aa23T cell lines, respectively. The authors, moreover, thank Markus Höpfler for assistance with some infection experiments, and Nikolaus Leisch and Daniela Gruber for advice and assistance with electron microscopy.
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: Barbara S. Sixt is recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences at the Department of Microbial Ecology, University of Vienna, Austria. This work was funded by Austrian Science Fund (FWF) grant Y277-B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257. doi: 10.1038/bjc.1972.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35:495–516. doi: 10.1080/01926230701320337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000;45:528–537. doi: 10.1016/s0008-6363(99)00384-3. [DOI] [PubMed] [Google Scholar]
- 4.Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ. 2008;15:243–250. doi: 10.1038/sj.cdd.4402184. [DOI] [PubMed] [Google Scholar]
- 5.Krysko DV, Vanden Berghe T, D'Herde K, Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods. 2008;44:205–221. doi: 10.1016/j.ymeth.2007.12.001. [DOI] [PubMed] [Google Scholar]
- 6.Duprez L, Wirawan E, Vanden Berghe T, Vandenabeele P. Major cell death pathways at a glance. Microbes Infect. 2009;11:1050–1062. doi: 10.1016/j.micinf.2009.08.013. [DOI] [PubMed] [Google Scholar]
- 7.Ameisen JC. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 2002;9:367–393. doi: 10.1038/sj.cdd.4400950. [DOI] [PubMed] [Google Scholar]
- 8.Huettenbrenner S, Maier S, Leisser C, Polgar D, Strasser S, et al. The evolution of cell death programs as prerequisites of multicellularity. Mutat Res. 2003;543:235–249. doi: 10.1016/s1383-5742(02)00110-2. [DOI] [PubMed] [Google Scholar]
- 9.Kornbluth S, White K. Apoptosis in Drosophila: neither fish nor fowl (nor man, nor worm). J Cell Sci. 2005;118:1779–1787. doi: 10.1242/jcs.02377. [DOI] [PubMed] [Google Scholar]
- 10.Chowdhury I, Tharakan B, Bhat GK. Caspases - an update. Comp Biochem Physiol B Biochem Mol Biol. 2008;151:10–27. doi: 10.1016/j.cbpb.2008.05.010. [DOI] [PubMed] [Google Scholar]
- 11.Cooper DM, Granville DJ, Lowenberger C. The insect caspases. Apoptosis. 2009;14:247–256. doi: 10.1007/s10495-009-0322-1. [DOI] [PubMed] [Google Scholar]
- 12.Labbé K, Saleh M. Cell death in the host response to infection. Cell Death Differ. 2008;15:1339–1349. doi: 10.1038/cdd.2008.91. [DOI] [PubMed] [Google Scholar]
- 13.Häcker G, Kirschnek S, Fischer SF. Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus. Med Microbiol Immunol. 2006;195:11–19. doi: 10.1007/s00430-005-0239-4. [DOI] [PubMed] [Google Scholar]
- 14.Faherty CS, Maurelli AT. Staying alive: bacterial inhibition of apoptosis during infection. Trends Microbiol. 2008;16:173–180. doi: 10.1016/j.tim.2008.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. PLoS Pathog. 2008;4:e1000018. doi: 10.1371/journal.ppat.1000018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lamkanfi M, Dixit VM. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe. 2010;8:44–54. doi: 10.1016/j.chom.2010.06.007. [DOI] [PubMed] [Google Scholar]
- 17.Ying S, Pettengill M, Ojcius DM, Häcker G. Host-Cell Survival and Death During Chlamydia Infection. Curr Immunol Rev. 2007;3:31–40. doi: 10.2174/157339507779802179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sharma M, Rudel T. Apoptosis resistance in Chlamydia-infected cells: a fate worse than death? FEMS Immunol Med Microbiol. 2009;55:154–161. doi: 10.1111/j.1574-695X.2008.00515.x. [DOI] [PubMed] [Google Scholar]
- 19.Wright HR, Turner A, Taylor HR. Trachoma. Lancet. 2008;371:1945–1954. doi: 10.1016/S0140-6736(08)60836-3. [DOI] [PubMed] [Google Scholar]
- 20.Bebear C, de Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect. 2009;15:4–10. doi: 10.1111/j.1469-0691.2008.02647.x. [DOI] [PubMed] [Google Scholar]
- 21.Blasi F, Tarsia P, Aliberti S. Chlamydophila pneumoniae. Clin Microbiol Infect. 2009;15:29–35. doi: 10.1111/j.1469-0691.2008.02130.x. [DOI] [PubMed] [Google Scholar]
- 22.Horn M. Chlamydiae as symbionts in eukaryotes. Annu Rev Microbiol. 2008;62:113–131. doi: 10.1146/annurev.micro.62.081307.162818. [DOI] [PubMed] [Google Scholar]
- 23.Abdelrahman YM, Belland RJ. The chlamydial developmental cycle. FEMS Microbiol Rev. 2005;29:949–959. doi: 10.1016/j.femsre.2005.03.002. [DOI] [PubMed] [Google Scholar]
- 24.Corsaro D, Venditti D. Diversity of the parachlamydiae in the environment. Crit Rev Microbiol. 2006;32:185–199. doi: 10.1080/10408410601023102. [DOI] [PubMed] [Google Scholar]
- 25.Kahane S, Dvoskin B, Mathias M, Friedman MG. Infection of Acanthamoeba polyphaga with Simkania negevensis and S. negevensis survival within amoebal cysts. Appl Environ Microbiol. 2001;67:4789–4795. doi: 10.1128/AEM.67.10.4789-4795.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Michel R, Müller KD, Zöller L, Walochnik J, Hartmann M, et al. Free-living amoebae serve as a host for the Chlamydia-like bacterium Simkania negevensis. Acta Protozoologica. 2005;44:113–121. [Google Scholar]
- 27.Friedman MG, Dvoskin B, Kahane S. Infections with the chlamydia-like microorganism Simkania negevensis, a possible emerging pathogen. Microbes Infect. 2003;5:1013–1021. doi: 10.1016/s1286-4579(03)00188-6. [DOI] [PubMed] [Google Scholar]
- 28.Kahane S, Fruchter D, Dvoskin B, Friedman MG. Versatility of Simkania negevensis infection in vitro and induction of host cell inflammatory cytokine response. J Infect. 2007;55:e13–21. doi: 10.1016/j.jinf.2007.03.002. [DOI] [PubMed] [Google Scholar]
- 29.Kahane S, Dvoskin B, Friedman MG. The role of monocyte/macrophages as vehicles of dissemination of Simkania negevensis: an in vitro simulation model. FEMS Immunol Med Microbiol. 2008;52:219–227. doi: 10.1111/j.1574-695X.2007.00361.x. [DOI] [PubMed] [Google Scholar]
- 30.Casson N, Michel R, Müller KD, Aubert JD, Greub G. Protochlamydia naegleriophila as etiologic agent of pneumonia. Emerg Infect Dis. 2008;14:168–172. doi: 10.3201/eid1401.070980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Casson N, Entenza JM, Borel N, Pospischil A, Greub G. Murine model of pneumonia caused by Parachlamydia acanthamoebae. Microb Pathog. 2008;45:92–97. doi: 10.1016/j.micpath.2008.04.003. [DOI] [PubMed] [Google Scholar]
- 32.Haider S, Collingro A, Walochnik J, Wagner M, Horn M. Chlamydia-like bacteria in respiratory samples of community-acquired pneumonia patients. FEMS Microbiol Lett. 2008;281:198–202. doi: 10.1111/j.1574-6968.2008.01099.x. [DOI] [PubMed] [Google Scholar]
- 33.Greub G. Parachlamydia acanthamoebae, an emerging agent of pneumonia. Clin Microbiol Infect. 2009;15:18–28. doi: 10.1111/j.1469-0691.2008.02633.x. [DOI] [PubMed] [Google Scholar]
- 34.Maurin M, Bryskier A, Raoult D. Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae. Antimicrob Agents Chemother. 2002;46:3065–3067. doi: 10.1128/AAC.46.9.3065-3067.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Greub G, Mege JL, Raoult D. Parachlamydia acanthamoebae enters and multiplies within human macrophages and induces their apoptosis. Infect Immun. 2003;71:5979–5985. doi: 10.1128/IAI.71.10.5979-5985.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Collingro A, Poppert S, Heinz E, Schmitz-Esser S, Essig A, et al. Recovery of an environmental chlamydia strain from activated sludge by co-cultivation with Acanthamoeba sp. Microbiology. 2005;151:301–309. doi: 10.1099/mic.0.27406-0. [DOI] [PubMed] [Google Scholar]
- 37.Casson N, Medico N, Bille J, Greub G. Parachlamydia acanthamoebae enters and multiplies within pneumocytes and lung fibroblasts. Microbes Infect. 2006;8:1294–1300. doi: 10.1016/j.micinf.2005.12.011. [DOI] [PubMed] [Google Scholar]
- 38.Hayashi Y, Nakamura S, Matsuo J, Fukumoto T, Yoshida M, et al. Host range of obligate intracellular bacterium Parachlamydia acanthamoebae. Microbiol Immunol. 2010;54:707–713. doi: 10.1111/j.1348-0421.2010.00265.x. [DOI] [PubMed] [Google Scholar]
- 39.Roger T, Casson N, Croxatto A, Entenza JM, Pusztaszeri M, et al. Role of MyD88 and Toll-like receptors 2 and 4 in the sensing of Parachlamydia acanthamoebae. Infect Immun. 2010;78:5195–5201. doi: 10.1128/IAI.00786-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Deponte M. Programmed cell death in protists. Biochim Biophys Acta. 2008;1783:1396–1405. doi: 10.1016/j.bbamcr.2008.01.018. [DOI] [PubMed] [Google Scholar]
- 41.Ying S, Pettengill M, Latham ER, Walch A, Ojcius DM, et al. Premature apoptosis of Chlamydia-infected cells disrupts chlamydial development. J Infect Dis. 2008;198:1536–1544. doi: 10.1086/592755. [DOI] [PubMed] [Google Scholar]
- 42.Schneider I. Cell lines derived from late embryonic stages of Drosophila melanogaster. J Embryol Exp Morphol. 1972;27:353–365. [PubMed] [Google Scholar]
- 43.Vaughn JL, Goodwin RH, Tompkins GJ, McCawley P. The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae). In Vitro. 1977;13:213–217. doi: 10.1007/BF02615077. [DOI] [PubMed] [Google Scholar]
- 44.O'Neill SL, Pettigrew MM, Sinkins SP, Braig HR, Andreadis TG, et al. In vitro cultivation of Wolbachia pipientis in an Aedes albopictus cell line. Insect Mol Biol. 1997;6:33–39. doi: 10.1046/j.1365-2583.1997.00157.x. [DOI] [PubMed] [Google Scholar]
- 45.Kuo CC, Grayston T. Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun. 1976;13:1103–1109. doi: 10.1128/iai.13.4.1103-1109.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Kuo CC, Grayston JT. Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol. 1988;26:812–815. doi: 10.1128/jcm.26.5.812-815.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Yamaguchi T, Yamazaki T, Inoue M, Ogawa M, Shiga S, et al. Factors improving the propagation of Simkania negevensis strain Z in cell culture. Jpn J Infect Dis. 2004;57:103–106. [PubMed] [Google Scholar]
- 48.Collingro A, Toenshoff ER, Taylor MW, Fritsche TR, Wagner M, et al. ‘Candidatus Protochlamydia amoebophila’, an endosymbiont of Acanthamoeba spp. Int J Syst Evol Microbiol. 2005;55:1863–1866. doi: 10.1099/ijs.0.63572-0. [DOI] [PubMed] [Google Scholar]
- 49.Silva MT, do Vale A, dos Santos NM. Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications. Apoptosis. 2008;13:463–482. doi: 10.1007/s10495-008-0187-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kumarswamy R, Chandna S. Inhibition of microRNA-14 contributes to actinomycin-D-induced apoptosis in the Sf9 insect cell line. Cell Biol Int. 2010;34:851–857. doi: 10.1042/CBI20100035. [DOI] [PubMed] [Google Scholar]
- 51.Martelli AM, Zweyer M, Ochs RL, Tazzari PL, Tabellini G, et al. Nuclear apoptotic changes: an overview. J Cell Biochem. 2001;82:634–646. doi: 10.1002/jcb.1186. [DOI] [PubMed] [Google Scholar]
- 52.Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555–556. doi: 10.1038/284555a0. [DOI] [PubMed] [Google Scholar]
- 53.Nagata S, Nagase H, Kawane K, Mukae N, Fukuyama H. Degradation of chromosomal DNA during apoptosis. Cell Death Differ. 2003;10:108–116. doi: 10.1038/sj.cdd.4401161. [DOI] [PubMed] [Google Scholar]
- 54.Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Van Noorden CJ. The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition. Acta Histochem. 2001;103:241–251. doi: 10.1078/0065-1281-00601. [DOI] [PubMed] [Google Scholar]
- 56.Poppert S, Essig A, Marre R, Wagner M, Horn M. Detection and differentiation of Chlamydiae by fluorescence in situ hybridization. Appl Environ Microbiol. 2002;68:4081–4089. doi: 10.1128/AEM.68.8.4081-4089.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Wagner M, Horn M, Daims H. Fluorescence in situ hybridisation for the identification and characterisation of prokaryotes. Curr Opin Microbiol. 2003;6:302–309. doi: 10.1016/s1369-5274(03)00054-7. [DOI] [PubMed] [Google Scholar]
- 58.Kahane SEM, Friedman MG. Evidence that the novel microorganism ‘Z’ may belong to a new genus in the family Chlamydiaceae. FEMS Microbiol Lett. 1995;126:203–208. doi: 10.1111/j.1574-6968.1995.tb07417.x. [DOI] [PubMed] [Google Scholar]
- 59.Kahane S, Everett KD, Kimmel N, Friedman MG. Simkania negevensis strain ZT: growth, antigenic and genome characteristics. Int J Syst Bacteriol. 1999;49 Pt 2:815–820. doi: 10.1099/00207713-49-2-815. [DOI] [PubMed] [Google Scholar]
- 60.Kahane S, Kimmel N, Friedman MG. The growth cycle of Simkania negevensis. Microbiology. 2002;148:735–742. doi: 10.1099/00221287-148-3-735. [DOI] [PubMed] [Google Scholar]
- 61.Hackstadt T. Cell biology. In: Stephens RS, editor. Chlamydia. Washington DC: American Society of Microbiology; 1999. pp. 101–138. [Google Scholar]
- 62.Greub G, Raoult D. Crescent bodies of Parachlamydia acanthamoebae and its life cycle within Acanthamoeba polyphaga: an electron micrograph study. Appl Environ Microbiol. 2002;68:3076–3084. doi: 10.1128/AEM.68.6.3076-3084.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Derré I, Pypaert M, Dautry-Varsat A, Agaisse H. RNAi screen in Drosophila cells reveals the involvement of the Tom complex in Chlamydia infection. PLoS Pathog. 2007;3:1446–1458. doi: 10.1371/journal.ppat.0030155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Cherry S. Genomic RNAi screening in Drosophila S2 cells: what have we learned about host-pathogen interactions? Curr Opin Microbiol. 2008;11:262–270. doi: 10.1016/j.mib.2008.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Elwell CA, Ceesay A, Kim JH, Kalman D, Engel JN. RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog. 2008;4:e1000021. doi: 10.1371/journal.ppat.1000021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Thao ML, Baumann L, Hess JM, Falk BW, Ng JC, et al. Phylogenetic evidence for two new insect-associated Chlamydia of the family Simkaniaceae. Curr Microbiol. 2003;47:46–50. doi: 10.1007/s00284-002-3953-9. [DOI] [PubMed] [Google Scholar]
- 67.Kostanjsek R, Strus J, Drobne D, Avgustin G. ‘Candidatus Rhabdochlamydia porcellionis’, an intracellular bacterium from the hepatopancreas of the terrestrial isopod Porcellio scaber (Crustacea: Isopoda). Int J Syst Evol Microbiol. 2004;54:543–549. doi: 10.1099/ijs.0.02802-0. [DOI] [PubMed] [Google Scholar]
- 68.Corsaro D, Thomas V, Goy G, Venditti D, Radek R, et al. ‘Candidatus Rhabdochlamydia crassificans’, an intracellular bacterial pathogen of the cockroach Blatta orientalis (Insecta: Blattodea). Syst Appl Microbiol. 2007;30:221–228. doi: 10.1016/j.syapm.2006.06.001. [DOI] [PubMed] [Google Scholar]
- 69.Elwell C, Engel JN. Drosophila melanogaster S2 cells: a model system to study Chlamydia interaction with host cells. Cell Microbiol. 2005;7:725–739. doi: 10.1111/j.1462-5822.2005.00508.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Böhme L, Rudel T. Host cell death machinery as a target for bacterial pathogens. Microbes Infect. 2009;11:1063–1070. doi: 10.1016/j.micinf.2009.08.014. [DOI] [PubMed] [Google Scholar]
- 71.Hershberger PA, Dickson JA, Friesen PD. Site-specific mutagenesis of the 35-kilodalton protein gene encoded by Autographa californica nuclear polyhedrosis virus: cell line-specific effects on virus replication. J Virol. 1992;66:5525–5533. doi: 10.1128/jvi.66.9.5525-5533.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Clem RJ, Miller LK. Apoptosis reduces both the in vitro replication and the in vivo infectivity of a baculovirus. J Virol. 1993;67:3730–3738. doi: 10.1128/jvi.67.7.3730-3738.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Fan T, Lu H, Hu H, Shi L, McClarty GA, et al. Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med. 1998;187:487–496. doi: 10.1084/jem.187.4.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Fischer SF, Schwarz C, Vier J, Häcker G. Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells. Infect Immun. 2001;69:7121–7129. doi: 10.1128/IAI.69.11.7121-7129.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Rajalingam K, Al-Younes H, Muller A, Meyer TF, Szczepek AJ, et al. Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect Immun. 2001;69:7880–7888. doi: 10.1128/IAI.69.12.7880-7888.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Airenne S, Surcel HM, Tuukkanen J, Leinonen M, Saikku P. Chlamydia pneumoniae inhibits apoptosis in human epithelial and monocyte cell lines. Scand J Immunol. 2002;55:390–398. doi: 10.1046/j.1365-3083.2002.01075.x. [DOI] [PubMed] [Google Scholar]
- 77.Zhong Y, Weininger M, Pirbhai M, Dong F, Zhong G. Inhibition of staurosporine-induced activation of the proapoptotic multidomain Bcl-2 proteins Bax and Bak by three invasive chlamydial species. J Infect. 2006;53:408–414. doi: 10.1016/j.jinf.2005.12.028. [DOI] [PubMed] [Google Scholar]
- 78.Karunakaran K, Mehlitz A, Rudel T. Evolutionary conservation of infection-induced cell death inhibition among Chlamydiales. PLoS One. 2011;6:e22528. doi: 10.1371/journal.pone.0022528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Dean D, Powers VC. Persistent Chlamydia trachomatis infections resist apoptotic stimuli. Infect Immun. 2001;69:2442–2447. doi: 10.1128/IAI.69.4.2442-2447.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Perfettini JL, Ojcius DM, Andrews CW, Korsmeyer SJ, Rank RG, et al. Role of proapoptotic BAX in propagation of Chlamydia muridarum (the mouse pneumonitis strain of Chlamydia trachomatis) and the host inflammatory response. J Biol Chem. 2003;278:9496–9502. doi: 10.1074/jbc.M211275200. [DOI] [PubMed] [Google Scholar]
- 81.Ojcius DM, Souque P, Perfettini JL, Dautry-Varsat A. Apoptosis of epithelial cells and macrophages due to infection with the obligate intracellular pathogen Chlamydia psittaci. J Immunol. 1998;161:4220–4226. [PubMed] [Google Scholar]
- 82.Schöier J, Öllinger K, Kvarnström M, Söderlund G, Kihlström E. Chlamydia trachomatis-induced apoptosis occurs in uninfected McCoy cells late in the developmental cycle and is regulated by the intracellular redox state. Microb Pathog. 2001;31:173–184. doi: 10.1006/mpat.2001.0460. [DOI] [PubMed] [Google Scholar]
- 83.Perfettini JL, Reed JC, Israel N, Martinou JC, Dautry-Varsat A, et al. Role of Bcl-2 family members in caspase-independent apoptosis during Chlamydia infection. Infect Immun. 2002;70:55–61. doi: 10.1128/IAI.70.1.55-61.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Ying S, Fischer SF, Pettengill M, Conte D, Paschen SA, et al. Characterization of host cell death induced by Chlamydia trachomatis. Infect Immun. 2006;74:6057–6066. doi: 10.1128/IAI.00760-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Hybiske K, Stephens RS. Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci U S A. 2007;104:11430–11435. doi: 10.1073/pnas.0703218104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Wang C, Youle RJ. The role of mitochondria in apoptosis*. Annu Rev Genet. 2009;43:95–118. doi: 10.1146/annurev-genet-102108-134850. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, et al. Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med. 2004;200:905–916. doi: 10.1084/jem.20040402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Dong F, Pirbhai M, Xiao Y, Zhong Y, Wu Y, et al. Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells. Infect Immun. 2005;73:1861–1864. doi: 10.1128/IAI.73.3.1861-1864.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Ying S, Seiffert BM, Hacker G, Fischer SF. Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis. Infect Immun. 2005;73:1399–1403. doi: 10.1128/IAI.73.3.1399-1403.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Hess S, Rheinheimer C, Tidow F, Bartling G, Kaps C, et al. The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes. Arthritis Rheum. 2001;44:2392–2401. doi: 10.1002/1529-0131(200110)44:10<2392::aid-art404>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
- 91.Hess S, Peters J, Bartling G, Rheinheimer C, Hegde P, et al. More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation. Cell Microbiol. 2003;5:785–795. doi: 10.1046/j.1462-5822.2003.00319.x. [DOI] [PubMed] [Google Scholar]
- 92.Rajalingam K, Sharma M, Lohmann C, Oswald M, Thieck O, et al. Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells. PLoS One. 2008;3:e3102. doi: 10.1371/journal.pone.0003102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Orme M, Meier P. Inhibitor of apoptosis proteins in Drosophila: gatekeepers of death. Apoptosis. 2009;14:950–960. doi: 10.1007/s10495-009-0358-2. [DOI] [PubMed] [Google Scholar]
- 94.Xia M, Bumgarner RE, Lampe MF, Stamm WE. Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect Dis. 2003;187:424–434. doi: 10.1086/367962. [DOI] [PubMed] [Google Scholar]
- 95.Rajalingam K, Sharma M, Paland N, Hurwitz R, Thieck O, et al. IAP-IAP complexes required for apoptosis resistance of C. trachomatis-infected cells. PLoS Pathog. 2006;2:e114. doi: 10.1371/journal.ppat.0020114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 1999;442:117–121. doi: 10.1016/s0014-5793(98)01640-8. [DOI] [PubMed] [Google Scholar]
- 97.Rozman-Pungercar J, Kopitar-Jerala N, Bogyo M, Turk D, Vasiljeva O, et al. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ. 2003;10:881–888. doi: 10.1038/sj.cdd.4401247. [DOI] [PubMed] [Google Scholar]
- 98.Fields KA, Hackstadt T. The chlamydial inclusion: escape from the endocytic pathway. Annu Rev Cell Dev Biol. 2002;18:221–245. doi: 10.1146/annurev.cellbio.18.012502.105845. [DOI] [PubMed] [Google Scholar]
- 99.Croxatto A, Greub G. Early intracellular trafficking of Waddlia chondrophila in human macrophages. Microbiology. 2010;156:340–355. doi: 10.1099/mic.0.034546-0. [DOI] [PubMed] [Google Scholar]
- 100.Greub G, Mege JL, Gorvel JP, Raoult D, Meresse S. Intracellular trafficking of Parachlamydia acanthamoebae. Cell Microbiol. 2005;7:581–589. doi: 10.1111/j.1462-5822.2004.00488.x. [DOI] [PubMed] [Google Scholar]
- 101.Chauvier D, Ankri S, Charriaut-Marlangue C, Casimir R, Jacotot E. Broad-spectrum caspase inhibitors: from myth to reality? Cell Death Differ. 2007;14:387–391. doi: 10.1038/sj.cdd.4402044. [DOI] [PubMed] [Google Scholar]
- 102.Eley A, Hosseinzadeh S, Hakimi H, Geary I, Pacey AA. Apoptosis of ejaculated human sperm is induced by co-incubation with Chlamydia trachomatis lipopolysaccharide. Hum Reprod. 2005;20:2601–2607. doi: 10.1093/humrep/dei082. [DOI] [PubMed] [Google Scholar]
- 103.Equils O, Lu D, Gatter M, Witkin SS, Bertolotto C, et al. Chlamydia heat shock protein 60 induces trophoblast apoptosis through TLR4. J Immunol. 2006;177:1257–1263. doi: 10.4049/jimmunol.177.2.1257. [DOI] [PubMed] [Google Scholar]
- 104.Jha R, Vardhan H, Bas S, Salhan S, Mittal A. Chlamydia trachomatis heat shock proteins 60 and 10 induce apoptosis in endocervical epithelial cells. Inflamm Res. 2011;60:69–78. doi: 10.1007/s00011-010-0237-x. [DOI] [PubMed] [Google Scholar]
- 105.Gonzalez-Robles A, Castanon G, Cristobal-Ramos AR, Lazaro-Haller A, Omana-Molina M, et al. Acanthamoeba castellanii: structural basis of the cytopathic mechanisms. Exp Parasitol. 2006;114:133–140. doi: 10.1016/j.exppara.2006.02.023. [DOI] [PubMed] [Google Scholar]
- 106.Moulder JW, Hatch TP, Byrne GI, Kellogg KR. Immediate toxicity of high multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells). Infect Immun. 1976;14:277–289. doi: 10.1128/iai.14.1.277-289.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Chang GT, Moulder JW. Loss of inorganic ions from host cells infected with Chlamydia psittaci. Infect Immun. 1978;19:827–832. doi: 10.1128/iai.19.3.827-832.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Kuo CC. Immediate cytotoxicity of Chlamydia trachomatis for mouse peritoneal macrophages. Infect Immun. 1978;20:613–618. doi: 10.1128/iai.20.3.613-618.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Perfettini JL, Darville T, Gachelin G, Souque P, Huerre M, et al. Effect of Chlamydia trachomatis infection and subsequent tumor necrosis factor alpha secretion on apoptosis in the murine genital tract. Infect Immun. 2000;68:2237–2244. doi: 10.1128/iai.68.4.2237-2244.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Greene W, Xiao Y, Huang Y, McClarty G, Zhong G. Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immun. 2004;72:451–460. doi: 10.1128/IAI.72.1.451-460.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Stenner-Liewen F, Liewen H, Zapata JM, Pawlowski K, Godzik A, et al. CADD, a Chlamydia protein that interacts with death receptors. J Biol Chem. 2002;277:9633–9636. doi: 10.1074/jbc.C100693200. [DOI] [PubMed] [Google Scholar]
- 112.Belland RJ, Scidmore MA, Crane DD, Hogan DM, Whitmire W, et al. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A. 2001;98:13984–13989. doi: 10.1073/pnas.241377698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Horn M, Collingro A, Schmitz-Esser S, Beier CL, Purkhold U, et al. Illuminating the evolutionary history of chlamydiae. Science. 2004;304:728–730. doi: 10.1126/science.1096330. [DOI] [PubMed] [Google Scholar]
- 114.Greub G, Kebbi-Beghdadi C, Bertelli C, Collyn F, Riederer BM, et al. High throughput sequencing and proteomics to identify immunogenic proteins of a new pathogen: the dirty genome approach. PLoS One. 2009;4:e8423. doi: 10.1371/journal.pone.0008423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Collingro A, Tischler P, Weinmaier T, Penz T, Heinz E, et al. Unity in Variety - the Pan-Genome of the Chlamydiae. Mol Biol Evol. 2011 doi: 10.1093/molbev/msr161. DOI: 10.1093/molbev/msr161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Fischer SF, Harlander T, Vier J, Häcker G. Protection against CD95-induced apoptosis by chlamydial infection at a mitochondrial step. Infect Immun. 2004;72:1107–1115. doi: 10.1128/IAI.72.2.1107-1115.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Wizel B, Nystrom-Asklin J, Cortes C, Tvinnereim A. Role of CD8(+)T cells in the host response to Chlamydia. Microbes Infect. 2008;10:1420–1430. doi: 10.1016/j.micinf.2008.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Kahane S, Gonen R, Sayada C, Elion J, Friedman MG. Description and partial characterization of a new Chlamydia-like microorganism. FEMS Microbiol Lett. 1993;109:329–333. doi: 10.1016/0378-1097(93)90041-y. [DOI] [PubMed] [Google Scholar]
- 119.Corsaro D, Venditti D, Valassina M. New parachlamydial 16S rDNA phylotypes detected in human clinical samples. Res Microbiol. 2002;153:563–567. doi: 10.1016/s0923-2508(02)01369-4. [DOI] [PubMed] [Google Scholar]
- 120.Heinz E, Rockey DD, Montanaro J, Aistleitner K, Wagner M, et al. Inclusion membrane proteins of Protochlamydia amoebophila UWE25 reveal a conserved mechanism for host cell interaction among the Chlamydiae. J Bacteriol. 2010;192:5093–5102. doi: 10.1128/JB.00605-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Daims H, Stoecker K, Wagner M. Fluorescence in situ hybridization for the detection of prokaryotes. In: Osborn AM, Smith CJ, editors. Advanced Methods in Molecular Microbial Ecology. Abingdon, UK: Bios-Garland; 2005. pp. 213–239. [Google Scholar]
- 122.Amann R, Binder BJ, Olson RJ, Chisholm SW, Devereux R, et al. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol. 1990;56:1919–1925. doi: 10.1128/aem.56.6.1919-1925.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.